Therapy for urogenital disorders in postmenopausal women

Abstract

Data are presented on the stages of aging of the female reproductive system and the symptoms developing in these age periods. It is noted that the pathogenesis of development of urogenital disorders are connected with decrease in the level of estrogens in the peri- and postmenorausal period. Effective therapy for women with vaginal atrophy is the administration of estriol preparations (Оvestin) in the form of a cream or vaginal suppositories.

Keywords

• climacteric
• menopause
• urogenital disorders
• fsh
• estradiol anti-mullerian hormone
• vaginal atrophy
• ovestin
• therapy regimens